Imetelstat
Geron Corporation
['mds']
#asco23 #mdssm zeidan: transfusion independence at 8 wks 40% w imetelstat vs 15% placebo. 13.6% vs 1.7% at one year.median dor 52 vs 13 weeks. median 3.6g/dl rise in imetelstat arm vs 0.8 w placebo (wow!). 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)